Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store

Stock Information for Patriot National Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Patriot National Inc - Ordinary Shares

Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law
FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis
Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update
Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference
Phexxi -- A Non?Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy
Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting
Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1
Evofem Reports First Quarter 2025 Financial Results and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.